Indeed, constitutive FLT3 signaling upregulates the anti-apoptotic mediator MCL-1 [45]; siRNA-mediated MCL-1 inhibition restores the sensitivity of FLT3-ITD AML to therapy [45]. The gene discussed is FLT3; the disease is acute myeloid leukemia.